U.S. FDA Staff Questions Johnson & Johnson Antibiotic Studies

15 Jul 2008

·www.biospace.com

WASHINGTON, July 14 (Reuters) - U.S. drug reviewers have major concerns about effectiveness data supplied by Johnson & Johnson in a bid to win approval for wider use of its Doribax antibiotic, documents released on Monday said.

Organizations

Johnson & Johnson

Indications

Targets

Drugs

Doripenem

Chat with Hiro

Hot reports

GPRC5D Target Patent Research Report

Patsnap Synapse

Global Drug R&D Express (July 2024)

PatSnap Synapse

siRNA Drug Amvuttra Patent Research and Practical Operation Guide

Patsnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.